LungenClinic Grosshansdorf   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Hamburg Germany (1900)

Organization Overview

First Clinical Trial
2006
NCT00678964
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

LungenClinic Grosshansdorf | LungenClinic Grosshansdorf, Germany | LungenClinic Grosshansdorf GmbH | LungenClinic Grosshansdorf GmbH Wöhrendamm 80 22927 Großhansdorf GERMANY | Pulmonary Research Institute at LungenClinic Grosshansdorf, German Center for Lung Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Adenocarcinoma of Lung (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Lung Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 11